Literature DB >> 23220891

Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis.

Tobias Heye1, Elmar M Merkle, Caecilia S Reiner, Matthew S Davenport, Jeffrey J Horvath, Sebastian Feuerlein, Steven R Breault, Peter Gall, Mustafa R Bashir, Brian M Dale, Atilla P Kiraly, Daniel T Boll.   

Abstract

PURPOSE: To compare the inter- and intraobserver variability with manual region of interest (ROI) placement versus that with software-assisted semiautomatic lesion segmentation and histogram analysis with respect to quantitative dynamic contrast material-enhanced (DCE) MR imaging determinations of the volume transfer constant (K(trans)).
MATERIALS AND METHODS: The study was approved by the institutional review board and compliant with HIPAA. The requirement to obtain informed consent was waived. Fifteen DCE MR imaging studies of the female pelvis defined the study group. Uterine fibroids were used as a perfusion model. Three varying types of lesion measurements were performed by five readers on each study by using DCE MR imaging perfusion analysis software with manual ROI placement and a semiautomatic lesion segmentation and histogram analysis solution. Intra- and interreader variability of measurements of K(trans) with the different measurement types was calculated.
RESULTS: The overall interobserver variability of K(trans) with manual ROI placement (mean, 28.5% ± 9.3) was reduced by 42.5% when the semiautomatic, software-assisted lesion measurement method was used (16.4% ± 6.2). Whole-lesion measurement showed the lowest interobserver variability with both measurement methods (20.1% ± 4.3 with the manual method vs 10.8% ± 2.6 with the semiautomatic method). The overall intrareader variability with the manual ROI method (7.6% ± 10.6) was not significantly different from that with the semiautomatic method (7.3% ± 10.8), but the intraclass correlation coefficient for intrareader reproducibility improved from 0.86 overall with the manual method to 0.99 with the semiautomatic method.
CONCLUSION: A semiautomatic lesion segmentation and histogram analysis approach can provide a significant reduction in interobserver variability for DCE MR imaging measurements of K(trans) when compared with manual ROI methods, whereas intraobserver reproducibility is improved to some extent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220891     DOI: 10.1148/radiol.12120255

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  42 in total

1.  Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication.

Authors:  Geewon Lee; Hyunjin Park; Insuk Sohn; Seung-Hak Lee; So Hee Song; Hyeseung Kim; Kyung Soo Lee; Young Mog Shim; Ho Yun Lee
Journal:  Oncologist       Date:  2018-04-05

2.  Repeatability of dynamic contrast enhanced vp parameter in healthy subjects and patients with brain tumors.

Authors:  Moran Artzi; Gilad Liberman; Deborah T Blumenthal; Felix Bokstein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2018-11-03       Impact factor: 4.130

3.  Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer.

Authors:  Catherine Coolens; Brandon Driscoll; Warren Foltz; Igor Svistoun; Noha Sinno; Caroline Chung
Journal:  Br J Radiol       Date:  2019-02-26       Impact factor: 3.039

4.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

5.  Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.

Authors:  Arun Chockalingam; Rafael Duran; Jae Ho Sohn; Rüdiger Schernthaner; Julius Chapiro; Howard Lee; Sonia Sahu; Sonny Nguyen; Jean-François Geschwind; MingDe Lin
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

6.  Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate.

Authors:  Soudabeh Kargar; Eric A Borisch; Adam T Froemming; Akira Kawashima; Lance A Mynderse; Eric G Stinson; Joshua D Trzasko; Stephen J Riederer
Journal:  Magn Reson Imaging       Date:  2017-12-24       Impact factor: 2.546

7.  Region of interest-based versus whole-lung segmentation-based approach for MR lung perfusion quantification in 2-year-old children after congenital diaphragmatic hernia repair.

Authors:  M Weis; V Sommer; F G Zöllner; C Hagelstein; K Zahn; T Schaible; S O Schoenberg; K W Neff
Journal:  Eur Radiol       Date:  2016-04-06       Impact factor: 5.315

8.  Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.

Authors:  David Bonekamp; Susanne Bonekamp; Vivek Gowdra Halappa; Jean-Francois H Geschwind; John Eng; Celia Pamela Corona-Villalobos; Timothy M Pawlik; Ihab R Kamel
Journal:  Eur J Radiol       Date:  2013-12-03       Impact factor: 3.528

9.  Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.

Authors:  Céline Giraudeau; Benjamin Leporq; Sabrina Doblas; Matthieu Lagadec; Catherine M Pastor; Jean-Luc Daire; Bernard E Van Beers
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

10.  A majority rule approach for region-of-interest-guided streamline fiber tractography.

Authors:  L M Colon-Perez; W Triplett; A Bohsali; M Corti; P T Nguyen; C Patten; T H Mareci; C C Price
Journal:  Brain Imaging Behav       Date:  2016-12       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.